Gilead Seeks FDA Approval for Remdesivir

TUESDAY, Aug. 11, 2020 -- Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said. " Today ' s filing is an...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news